Ignite Creation Date:
2024-05-05 @ 10:42 PM
Last Modification Date:
2024-10-26 @ 10:22 AM
Study NCT ID:
NCT01160289
Status:
COMPLETED
Last Update Posted:
2019-04-09
First Post:
2010-07-08
Brief Title:
A Study of LY900010 in Erectile Dysfunction
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
A Study of LY900010 LY2452473 Tadalafil in the Treatment of Men With Erectile Dysfunction
Status:
COMPLETED
Status Verified Date:
2019-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of the study is to compare the efficacy of LY2452473 tadalafil to tadalafil alone in improving the erectile function EF of men with erectile dysfunction ED who incompletely respond to tadalafil alone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| I4K-MC-GPEC | OTHER | Eli Lilly and Company | None |